|
| Exchange Received Time 05/12/2017 16:05:15 Exchange Disseminated Time 05/12/2017 16:05:20 Time Taken 00:00:05 | we hereby intimate you that SHILPA MEDICARE LIMITED has received 483 Observations from the United States Food & Drug Administration (USFDA) in relation to SEZ Formulation Facilities situated at Jadcherla, Telangana (near Hyderabad) as under;
a) Total 10 observations were cited during the close up meeting.
b) 7 observations are improvement in procedures and practices.
c) 3 observations are related to setting of analytical specifications, test procedures and method validation.
This is for your information and doing the needful
|
|
|